SEMAGLUTIDE (Rybelsus®)

Clinical Indication

Type 2 diabetes

Date of classification

September 2020

Review date

June 2021

Green

Drugs for which GPs would normally take full responsibility for prescribing and monitoring. Drugs included in this list have been specifically considered by LMSG.